top of page

About Us
Journal
Technology
Pipeline
Engage
- Canurta Day '23
- Merch
Contact

Canurta Website Images.jpg

Canurta Journal

A collection of news, scientific papers and impact across industry, academia and events.

All Posts
Research
Events
Awards
News
Blog

FDA Drug Approvals in 2023: Insights into Trends and Molecule Types

Aug 21

FDA Drug Approvals in 2023: Insights into Trends and Molecule Types

The Gut-Brain Axis: Exploring the Impact of Gut Microbiota-Derived Phenolic Compounds on Neurocognition

Aug 14

The Gut-Brain Axis: Exploring the Impact of Gut Microbiota-Derived Phenolic Compounds on Neurocognition

Cannflavin-C Counters Heart Enlargement Triggered by Angiotensin II: Impact on Enzymes and Fatty Acid Metabolism

Aug 7

Cannflavin-C Counters Heart Enlargement Triggered by Angiotensin II: Impact on Enzymes and Fatty Acid Metabolism

Canurta Therapeutics Secures First US Patent for Novel Bioactive Polyphenol Extraction Process

Jul 31

Canurta Therapeutics Secures First US Patent for Novel Bioactive Polyphenol Extraction Process

Exploring Cannabis Pharmacology: Beyond THC and CBD

Jul 24

Exploring Cannabis Pharmacology: Beyond THC and CBD

AI: Transforming the Future of Nutraceuticals

Jul 17

AI: Transforming the Future of Nutraceuticals

The Protective Role of Cannflavins A and B Against Cell Death in Human Skin Cells

Jul 8

The Protective Role of Cannflavins A and B Against Cell Death in Human Skin Cells

Investigation of cannflavins from Cannabis sativa as potential anti-SARS-CoV-2 agents

Jul 1

Investigation of cannflavins from Cannabis sativa as potential anti-SARS-CoV-2 agents

The Antiatherogenic Potential of Flavonoids in Cardiovascular Health

Jun 24

The Antiatherogenic Potential of Flavonoids in Cardiovascular Health

Jun 17

Cannflavin A Displays Both a Hormetic and Neuroprotective Profile Against Alzheimer's Disease Progression

Preclinical Research with a First-in-Class ALS Therapy Formulation

May 24

Preclinical Research with a First-in-Class ALS Therapy Formulation

Reflecting on the ALS Drug Development Summit in Boston

May 24

Reflecting on the ALS Drug Development Summit in Boston

The Comprehensive Neurotherapeutic Potential of Cannabis sativa

Apr 9

The Comprehensive Neurotherapeutic Potential of Cannabis sativa

Chemistry and Activities of Cannflavins

Mar 19

Chemistry and Activities of Cannflavins

Innovating Plant Flavonoid Production

Mar 14

Innovating Plant Flavonoid Production

Canurta Inc. Unveils Strategic Reorganization & Rebranding: Introducing Canurta Therapeutics and Canurta Naturals

Feb 8

Canurta Inc. Unveils Strategic Reorganization & Rebranding: Introducing Canurta Therapeutics and Canurta Naturals

Can Cannflavins Treat Brain Cancer? Study Shows Molecules Have the Potential to Attack Tumour Cells

Nov 16, 2023

Can Cannflavins Treat Brain Cancer? Study Shows Molecules Have the Potential to Attack Tumour Cells

The Potential Benefits of Cannflavins for ALS Symptom Management

Nov 1, 2023

The Potential Benefits of Cannflavins for ALS Symptom Management

Exploring Canurta's Dual Inhibition Approach to Inflammation

Oct 25, 2023

Exploring Canurta's Dual Inhibition Approach to Inflammation

Therapeutic Potential and Predictive Pharmaceutical Modeling of Stilbenes

Oct 17, 2023

Therapeutic Potential and Predictive Pharmaceutical Modeling of Stilbenes

1

2

Transforming Rare Polyphenols into Botanical Drugs

hello@canurta.com |

© 2024 Canurta, Inc. All rights reserved.

Stay connected & receive updates on new discoveries, product innovation and more.

Thank you for subscribing.

About Us
Journal
Technology
Pipeline
Engage
- Canurta Day '23
- Merch
Contact

bottom of page